Three-dose Covid-19 vaccine produces strong immune response in children ages 6 months to 5 years, Pfizer and BioNTech say
CNN
Three child-size doses of the Pfizer/BioNTech Covid-19 vaccine appeared to be safe and showed a strong immune response in children ages 6 months to 5 years, the companies said Monday. The vaccine makers said they will finish submitting the trial data to the US Food and Drug Administration this week.
More Related News
5 things to know for June 10: European elections, Apple, Hostage rescue, Immigration, Trash balloons
CNN’s 5 Things brings you the news you need to know every morning.